Table 2.
Socio-demographic and clinical characteristics of 141 patients administered warfarin at Korle-bu Teaching Hospital in Accra
| Characteristic | Frequency, % |
|---|---|
| Age (years) (N = 141) | |
| Median (inter-quartile range) | 48 (34–58) |
| Gender (N = 141) | |
| Female | 79 (56.0) |
| Body mass index (N = 141) | |
| Normal (18.00–24.99 kg/m2) | 55 (39.0) |
| Overweight/Obese (≥ 25.00 kg/m2) | 86 (61.0) |
| Warfarin duration (months) (N = 139) | |
| Median (inter-quartile range) | 24 (10–72) |
| Diagnosis (N = 140) | |
| Mitral valve replacement | 63 (45.0) |
| Deep vein thrombosis | 51 (36.4) |
| Atrial fibrillation | 10 (7.2) |
| Pulmonary embolism | 16 (11.4) |
| Presence of side effects (N = 141) | |
| Yes | 27 (19.1) |
| No | 114 (80.9) |
| Other medication given (N = 141) | |
| Yes | 76 (53.9) |
| No | 65 (46.1) |
N number of study participants